Cargando…
Using Molecular Diagnostics to Develop Therapeutic Strategies for Carbapenem-Resistant Gram-Negative Infections
Infections caused by multidrug-resistant Gram-negative organisms have become a global threat. Such infections can be very difficult to treat, especially when they are caused by carbapenemase-producing organisms (CPO). Since infections caused by CPO tend to have worse outcomes than non-CPO infections...
Autor principal: | Tenover, Fred C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505994/ https://www.ncbi.nlm.nih.gov/pubmed/34650933 http://dx.doi.org/10.3389/fcimb.2021.715821 |
Ejemplares similares
-
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022) -
Editorial: The global threat of carbapenem-resistant gram-negative bacteria
por: Dropa, Milena, et al.
Publicado: (2022) -
Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens
por: Cruz-López, Flora, et al.
Publicado: (2022) -
Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development
por: Liao, Qiuxia, et al.
Publicado: (2023) -
Editorial: The global threat of carbapenem-resistant gram-negative bacteria, volume II
por: Daoud, Ziad, et al.
Publicado: (2023)